India To Centralize Drug, Device Purchases For Health Outlets
This article was originally published in PharmAsia News
Executive SummaryIndia's government plans to establish one place for government purchases of drugs and medical devices. The intention of the change is to provide greater transparency in government procurement of medicines for dispensaries and health-care centers. Currently, those buys are left to the centers themselves or to the state governments to buy the products they need. Under the new plan, a Medical Services Corp would be created as the central Indian government agency to buy drugs and devices. (Click here for more
You may also be interested in...
ConMed's CFO Todd Garner told delegates at the Jefferies Healthcare conference that the company's orthopedic franchise is focused on its pipeline and meeting customer's needs. See what the CFO said about it here.
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.